-

 As stated in the report of Credit Suisse, the third quarterly revenue of SH PHARMA (02607.HK)  +0.080 (+0.414%)    Short selling $643.69K; Ratio 4.148%   shot up 27.7% to RMB 24.703 billion. Excluding special items, the increasing rate of earnings recorded a year-on-year increase of 13.9%, an acceleration from 5.8% in the first half of the year. It is believed that the annual core earnings will record a double-digit growth. The target price of Shanghai Pharmaceuticals was lifted from $15.04 to $19, which represents 15x of P/E. The rating was maintained at Neutral.
 

Comments

Post a Comment

Popular posts from this blog

-
Image
CITIC Annual Net Profit Up 1.8% to $43.902B; Final Div $0.25 CITIC (00267.HK)    -0.160 (-1.447%)    Short selling $8.89M; Ratio 25.055%   announced that for the year ended December 2017, net profit rose 1.8% yearly to $43.902 billion, with an EPS of $1.51. A final dividend of $0.25 was declared. Profit contribution from financial sector of the company amounted to $39.5 billion, up 3% yearly. CITIC Construction continued to make inroads securing projects, both domestically and internationally, particularly along the Belt and Road corridor.
Read more
-
Hopewell Hold (00054) sells Hopewell Infr stake for $9.9B  Hopewell Holdings (00054) has agreed to sell 2.055 billion shares of Hopewell Highway Infrastructure (00737) , representing 66.69% of the issued share capital of the company, to Shenzhen Investment International Capital Holdings Infrastructure Co. to HK$9.865 billion in cash, or HK$4.8 per share, which has a discount of 3.61% to the closing price of HK$4.98 per share on 29 December 2017. Upon completion of the deal, the purchaser and parties acting in concert with it will own a total of 66.69% stake in Hopewell Highway Infrastructure and the purchaser will be required to make an unconditional mandatory cash offer for all other issued shares of Hopewell Highway Infrastructure also at HK$4.8 per share. The total consideration of the offer will be HK$4.927 billion assuming full acceptance of the offer. The offeror intends to maintain Hopewell Highway Infrastructure's share listing following the close of...
Read more
-
CLSA lowers Beijing Ent Water (00371) to HK$6   CLSA cut its target price for Beijing Enterprises Water (BEW)(00371) by 8% to HK$6, and reiterated its "buy" rating.   The research house said BEW's share price has dropped 14% in the last two trading days. First, the 2017 earnings results are below expectations. Second, management is guiding for 20-25% net profit growth for 2018, versus 30% in the past few years. Management now has a cautious approach to water PPP (public-private partnership) projects, which is not  necessarily bad.   CLSA cut its 2018-19 earnings forecasts by...
Read more